Juq-565

If "JUQ-565" refers to implementing a search functionality in a web application:

Without specific details on "JUQ-565," this approach provides a general framework for feature development. JUQ-565

Since the quantum layer already offers information‑theoretic security, the addition of a lattice‑based authentication layer ensures that the overall system remains secure even if future advances compromise the underlying lattice assumptions. This defense‑in‑depth approach aligns with the recommendations of the National Institute of Standards and Technology (NIST) for quantum‑ready infrastructures. If "JUQ-565" refers to implementing a search functionality

Orthotopic xenograft model: 5 × 10⁶ MDA‑MB‑468 cells (luciferase‑expressing) were implanted into the fourth mammary fat pad of female NOD‑SCID mice (6‑week old). Tumor volume was measured bi‑weekly by calipers (V = ½ L × W²). Mice were randomized (n = 10/group) to vehicle, JUQ‑565 (30 mg kg⁻¹ PO qd), carboplatin (50 mg kg⁻¹ i.p. q7d), or combination (JUQ‑565 + carboplatin). Treatment started when tumors reached ~100 mm³. Body weight and clinical signs were recorded throughout. Orthotopic xenograft model: 5 × 10⁶ MDA‑MB‑468 cells

Pharmacodynamic (PD) biomarker: Tumor biopsies harvested 4 h after the first dose were analyzed for p‑Akt and γ‑H2AX (DNA damage marker) by immunohistochemistry.

A focused library (n = 28) of analogues varying the para‑aryl substituent (F, Cl, Me, CF₃) and the heteroaryl side chain (pyridyl, quinolinyl, thiazolyl) was synthesized. Compounds were evaluated for PI3Kα inhibition and cellular GI₅₀ to delineate the pharmacophore.